105 related articles for article (PubMed ID: 16813834)
1. Rolling adhesion of alphaL I domain mutants decorrelated from binding affinity.
Pepper LR; Hammer DA; Boder ET
J Mol Biol; 2006 Jun; 360(1):37-44. PubMed ID: 16813834
[TBL] [Abstract][Full Text] [Related]
2. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow.
Eniola AO; Krasik EF; Smith LA; Song G; Hammer DA
Biophys J; 2005 Nov; 89(5):3577-88. PubMed ID: 16100282
[TBL] [Abstract][Full Text] [Related]
3. Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity.
Legge GB; Morris GM; Sanner MF; Takada Y; Olson AJ; Grynszpan F
Proteins; 2002 Aug; 48(2):151-60. PubMed ID: 12112684
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of LFA-1 and Mac-1 ligand binding domains.
Walters SE; Tang RH; Cheng M; Tan SM; Law SK
Biochem Biophys Res Commun; 2005 Nov; 337(1):142-8. PubMed ID: 16199219
[TBL] [Abstract][Full Text] [Related]
5. Transition from rolling to firm adhesion can be mimicked by extension of integrin alphaLbeta2 in an intermediate affinity state.
Salas A; Shimaoka M; Phan U; Kim M; Springer TA
J Biol Chem; 2006 Apr; 281(16):10876-82. PubMed ID: 16505487
[TBL] [Abstract][Full Text] [Related]
6. Isolation of αL I domain mutants mediating firm cell adhesion using a novel flow-based sorting method.
Pepper LR; Parthasarathy R; Robbins GP; Dang NN; Hammer DA; Boder ET
Protein Eng Des Sel; 2013 Aug; 26(8):515-21. PubMed ID: 23788664
[TBL] [Abstract][Full Text] [Related]
7. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1.
Legge GB; Kriwacki RW; Chung J; Hommel U; Ramage P; Case DA; Dyson HJ; Wright PE
J Mol Biol; 2000 Feb; 295(5):1251-64. PubMed ID: 10653701
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of I domain and global conformational changes in LFA-1: refinement of small molecule-I domain structure-activity relationships.
Larson RS; Davis T; Bologa C; Semenuk G; Vijayan S; Li Y; Oprea T; Chigaev A; Buranda T; Wagner CR; Sklar LA
Biochemistry; 2005 Mar; 44(11):4322-31. PubMed ID: 15766261
[TBL] [Abstract][Full Text] [Related]
9. Comparative normal mode analysis of LFA-1 integrin I-domains.
Gaillard T; Martin E; San Sebastian E; Cossío FP; Lopez X; Dejaegere A; Stote RH
J Mol Biol; 2007 Nov; 374(1):231-49. PubMed ID: 17919656
[TBL] [Abstract][Full Text] [Related]
10. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
Nam K; Maiorov V; Feuston B; Kearsley S
Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
[TBL] [Abstract][Full Text] [Related]
11. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
[TBL] [Abstract][Full Text] [Related]
12. A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function.
Woska JR; Shih D; Taqueti VR; Hogg N; Kelly TA; Kishimoto TK
J Leukoc Biol; 2001 Aug; 70(2):329-34. PubMed ID: 11493627
[TBL] [Abstract][Full Text] [Related]
13. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin alphaL I domains with high affinity and antagonist activity in vivo.
Shimaoka M; Lu C; Palframan RT; von Andrian UH; McCormack A; Takagi J; Springer TA
Proc Natl Acad Sci U S A; 2001 May; 98(11):6009-14. PubMed ID: 11353828
[TBL] [Abstract][Full Text] [Related]
14. The leukocyte function-associated antigen-1 (LFA-1)-binding site on ICAM-3 comprises residues on both faces of the first immunoglobulin domain.
Bell ED; May AP; Simmons DL
J Immunol; 1998 Aug; 161(3):1363-70. PubMed ID: 9686599
[TBL] [Abstract][Full Text] [Related]
15. Transition from rolling to firm adhesion is regulated by the conformation of the I domain of the integrin lymphocyte function-associated antigen-1.
Salas A; Shimaoka M; Chen S; Carman CV; Springer T
J Biol Chem; 2002 Dec; 277(52):50255-62. PubMed ID: 12368274
[TBL] [Abstract][Full Text] [Related]
16. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1.
Woska JR; Morelock MM; Jeanfavre DD; Bormann BJ
J Immunol; 1996 Jun; 156(12):4680-5. PubMed ID: 8648112
[TBL] [Abstract][Full Text] [Related]
17. Characterization of binding properties of ICAM-1 peptides to LFA-1: inhibitors of T-cell adhesion.
Anderson ME; Tejo BA; Yakovleva T; Siahaan TJ
Chem Biol Drug Des; 2006 Jul; 68(1):20-8. PubMed ID: 16923022
[TBL] [Abstract][Full Text] [Related]
18. Importance of force linkage in mechanochemistry of adhesion receptors.
Astrof NS; Salas A; Shimaoka M; Chen J; Springer TA
Biochemistry; 2006 Dec; 45(50):15020-8. PubMed ID: 17154539
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of monoclonal antibody to integrin alphaL beta2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding.
Tang RH; Tng E; Law SK; Tan SM
J Biol Chem; 2005 Aug; 280(32):29208-16. PubMed ID: 15958383
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins.
Kim M; Carman CV; Springer TA
Science; 2003 Sep; 301(5640):1720-5. PubMed ID: 14500982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
